✦ LIBER ✦

Pharmacologic inhibition of polo-like kinase 1 enhances paclitaxel-based cell killing in taxol-resistant ovarian cancer cells

✍ Scribed by Marcus, C.S.; Hood, B.L.; Wang, G.; Bateman, N.W.; Conrads, K.A.; Dubil, E.A.; Darcy, K.M.; Maxwell, G.L.; Hamilton, C.A.; Conrads, T.P.

Book ID: 126786996
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 91 KB
Volume: 133
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2014.03.326

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Calcium-dependent inhibition of polo-lik

Calcium-dependent inhibition of polo-like kinase 3 activity by CIB1 in breast cancer cells

✍ Meghna U. Naik; Ngoc T. Pham; Kristin Beebe; Wei Dai; Ulhas P. Naik 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 699 KB

## Abstract Members of the polo‐like kinases (Plk1, Plk2, Plk3 and Plk4) are involved in the regulation of various stages of the cell cycle and have been implicated in cancer progression. Unlike its other family members, the expression of Plk3 remains steady during cell cycle progression, suggestin

pH-Responsive Polymeric siRNA Carriers S

pH-Responsive Polymeric siRNA Carriers Sensitize Multidrug Resistant Ovarian Cancer Cells to Doxorubicin via Knockdown of Polo-like Kinase 1

✍ Benoit, Danielle S. W.; Henry, Scott M.; Shubin, Andrew D.; Hoffman, Allan S.; S 📂 Article 📅 2010 🏛 American Chemical Society 🌐 English ⚖ 730 KB

Silencing of Polo-Like Kinase (Plk) 1 vi

Silencing of Polo-Like Kinase (Plk) 1 via siRNA Causes Inhibition of Growth and Induction of Apoptosis in Human Esophageal Cancer Cells

✍ Bu, Youquan; Yang, Zhengmei; Li, Quanhai; Song, Fangzhou 📂 Article 📅 2008 🏛 S. Karger AG 🌐 English ⚖ 428 KB